Advertisement

Granulocyte Function in Patients Receiving Lithium Carbonate

  • Myron S. Cohen
  • Behnam Zahkireh
  • Julia A. Metcalf
  • Richard K. Root
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 127)

Abstract

Phagocytic cells provide protection against a wide variety of microbial pathogens. A depletion of polymorphonuclear leukocytes (PMNs) below a critical number (Bodey et al., 1966) and/or abnormality in their cellular function (Quie, 1975) is associated with serious infection. Therefore, agents capable of enhancing phagocyte number and function are of importance. The lithium ion (Li+) induces leukocytosis (Shopsin et al., 1971) and may diminish the neutropenia associated with cancer chemotherapy (Greco and Brereton, 1977; Charron et al., 1977; Stein et al., 1977). While such effects appear desirable, it is equally important that the functions of these phagocytic cells are preserved in their contribution to the host defense system. In this paper we shall report our investigation into the microbicidal ability of neutrophils obtained from patients receiving lithium carbonate (Li2CO3), and the in vitro effects of lithium chloride (LiCl) on several PMN functions.

Keywords

Acute Myeloid Leukemia Polymorphonuclear Leukocyte Phagocytic Activity Patient Seron Lithium Chloride 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bodey, G.P., Buckley, M., Sathe, Y.S., and Freireich, E.J., 1966, Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia, Ann, Intern, Med. 64:328.Google Scholar
  2. Charron, D., Barrett, A.J., Faille, A., Alby, N., Schmitt, T., and Degos, L., 1977, Lithium in acute myeloid leukemia, The Lancet 1:1307.CrossRefGoogle Scholar
  3. Clark, R.A. and Kimball, H.R., 1971, Defective granulocyte chemotaxis in Chediak-Higashi Syndrome, J. Clin. Invest. 50:2645.PubMedCrossRefGoogle Scholar
  4. Gelfand, E.W., Dosch, H., Hastings, D., and Shore, A., 1979, Lithium: A modulator of cyclic AMP-dependent events in lymphocytes?, Science 203:365.PubMedCrossRefGoogle Scholar
  5. Greco, F.A. and Brereton, H.D., 1977, Effect of lithium carbonate on the neutropenia caused by chemotherapy: A preliminary clinical trial, Oncology 34:153.PubMedCrossRefGoogle Scholar
  6. Hyams, J.S., Donaldson, M.H., Metcalf, J.A., and Root, R.K., 1978, Inhibition of human granulocyte function by methotrexate, Cancer Res. 38:650.PubMedGoogle Scholar
  7. MacGregor, R.R. and Dyson, W.L., 1978, Effect of lithium on granulocyte adherence, Clin. Res. 26:352A.Google Scholar
  8. Marchesi, J.T. and Florey, H.W., 1960, Electron micrographic observations on the emigration of leukocytes, Quart. Journ. Expt. Physio. 45:343.Google Scholar
  9. Miller, M.E., 1975, Pathology of chemotaxis and random mobility, Seminars in Hematology 12:59.PubMedGoogle Scholar
  10. Oliver, J.M., 1978, Cell biology of leukocyte abnormalities-membrane and cytoskeletal function in normal and defective cells, Am. J. Path. 93:221.PubMedGoogle Scholar
  11. Perez, H.D., Kaplan, H., Shenkman, L., Borkowsky, W., and Goldstein, I.M., 1979, Reversal of an abnormality of polymorphonuclear leukocyte chemo-taxis with lithium, Clin. Res. 27:353A.Google Scholar
  12. Quie, P.G., 1975, Pathology of bactericidal power of neutrophils, Seminars in Hematology 12:143.PubMedGoogle Scholar
  13. Rothstein, G., Clarkson, D.R., Larsen, W., Grosser, B.I., and Athens, J.W., 1978, Effect of lithium on neutrophil mass and production, N. Eng. J. Med. 298:178.CrossRefGoogle Scholar
  14. Root, R.K., Rosenthal, A.S., Balestran, D.J., 1972, Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi syndrome leukocytes, J. Clin, Invest. 51:649.CrossRefGoogle Scholar
  15. Shenkman, L., Borkowsky, W., Holzman, R.S., and Shopsin, B., 1978, Enhancement of lymphocyte and macrophage function in vitro by lithium chloride, Clin. Immunol. Immunopath. 10:187.CrossRefGoogle Scholar
  16. Shopsin, B., Friedman, R., and Gershon, S., 1971, Lithium and leukocytosis, Clin. Pharmcol. Ther. 12:923.Google Scholar
  17. Singer, I. and Rotenberg, D., 1973, Mechanism of lithium action, New Eng. J. Med. 289:254.PubMedCrossRefGoogle Scholar
  18. Stein, R.S., Beaman, C., Ali, M.Y., Hansen, R., Jenkins, D.D., and Jume’am, H.G., 1977, Lithium carbonate attenuation of chemotherapy-induced neutropenia, New. Eng. J. Med. 297:430.PubMedCrossRefGoogle Scholar
  19. Stein, R.S., Hansen, G.H., Koethe, S., and Hansen, R., 1978, Lithium induced granulocytosis, Ann. Intern. Med. 88:1978.Google Scholar
  20. Zigmond, S.H. and Hirsch, J.G., 1973, Leukocyte locomotion and chemotaxis. New methods for evaluation and demonstration of a cell derived chemotactic factor, J. Exp. Med. 137:387.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • Myron S. Cohen
    • 1
  • Behnam Zahkireh
    • 1
  • Julia A. Metcalf
    • 1
  • Richard K. Root
    • 1
  1. 1.Department of Internal MedicineYale University School of MedicineNew HavenUSA

Personalised recommendations